Certificate of Advanced Studies in Lung cancer - third cohort (CASLu3)

Collaborating university: University of Zurich

The Certificate of Advanced Studies in Lung cancer (CASLu) was launched in 2018 and is the first programme to focus on the improvement on both the clinical and the scientific aspects of improving quality in the management of patients with lung cancer and other thoracic malignancies.

This programme, which is offered on a part-time basis over 14 months, is divided into three attendance seminars and four online modules.

Upon successful completion of the programme, participants will obtain an academic certificate issued by the University of Zurich assigning 14 ECTS credits, equalling a work load of 420 hours and a diploma supplement by the University of Zurich.

LINK TO THE PLATFORM HERE.

The programme is designed for medical doctors (medical oncology, radiation oncology, thoracic surgery, radiology, nuclear medicine, pathology), but it is equally accessible to graduates in natural sciences, who are engaged in the field of oncology, especially in the field of thoracic malignancies.

Medical doctors:

Master degree from an accredited college or university in medicine or an equivalent degree at the level of state examination in medicine and have had at least two years' residency training in a relevant institution.

Natural scientists:

Master degree from an accredited college or university in a course of studies in natural sciences or an equivalent degree at the level of at least three years of studies or in a course of studies with essentially the same contents at an accredited college or university and at least two years of professional experience in oncology.  Examples of courses of study with essentially the same contents are biology, molecular medicine, biochemistry and pharmacology.

The following additional achievements will increase the assessment rate of the application:

• Further professional experience related to the course of studies
• Completion of an additional qualification in oncology
• Publications, as evidenced by cumulative impact factors greater than 10
• At least one year of relevant oncological experience in a foreign country

In keeping with the ESO mission, the cost of the CASLu programme is generously subsidized by the European School of Oncology (ESO).

The tuition fee which remains to be paid by each participant is EUR 5.400.

In a further effort to make the cost of this programme accessible to professionals living in emerging economies, a discounted fee of EUR 3.000 will be applied to residents of lower and middle income countries as defined by The World Bank.

The tuition fee includes:

1. Access to the modules via a dedicated online platform
2. Access to the in-person seminars foreseen by the programme, including registration for the indicated congresses and accommodation (ELCC 2023, ESMO Congress 2023, CASLu stand-alone seminar 2024)
3. Access to all exams required by the programme

The tuition fee does not include:

1. Travel to the in-person seminars

REFUNDS

Cancellation of participation in the programme should be submitted in writing. A refund of the tuition fee will be considered if the programme has not started yet and on a case by case basis.

Chairs

Alessandra Curioni, CH
Enriqueta Felip, ES
Matthias Guckenberger, CH
Rolf A. Stahel, CH

Scientific Directors

Keith Kerr, UK
Lukas Bubendorf, CH
Christian Britschgi, CH
Solange Peterss, CH
Sven Hillinger,, CH
Suresh Senan, NL
Pilar Garrido, ES
Martin Früh, CH

Conceptual Development and Organization

Anja Kühnis, CH
Alexandra Zampetti, CH

Application & programme time-line

Please contact azampetti@eso.net with any questions.